Patent · US Active

Anticancer compounds

US10357477B2 · kind B2 · utility

0Cited by

0References

14Claims

0Family size

Assignee

Regents of the University of Minnesota · US

Inventors

Liqiang Chen · Minneapolis, US
Teng Ai · Middleton, US

Key dates

Filing date	Sep 13, 2017
Grant date	Jul 23, 2019
Priority date	—
Expiry date	Sep 13, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D401/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides compounds having the general formula I: and salts thereof, wherein the variables RA, RB, RC, L1, L2, L3, A, B, C, X, Y, Z, E, m, n, and p have the meaning as described herein, and compositions containing such compounds and methods for using such compounds and compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.